CONTINUOUS NON-INVASIVE ANALYTE MEASUREMENT SYSTEM AND METHOD
20230122826 · 2023-04-20
Inventors
Cpc classification
A61B5/0095
HUMAN NECESSITIES
A61B5/145
HUMAN NECESSITIES
A61B5/1455
HUMAN NECESSITIES
G01N21/1702
PHYSICS
International classification
A61B5/00
HUMAN NECESSITIES
Abstract
A system and method for non-invasively measuring at least one analyte within a blood vessel is provided. The system includes an excitation light source having at least one excitation laser configured to selectively produce an excitation light beam, an interrogation light source having at least interrogation laser configured to selectively produce an interrogation light beam at a predetermined interrogation wavelength, a Fabry-Perot sensor configured to be transparent to excitation light, and to reflect interrogation light, at least one light beam steering device, a light detector, and a controller in communication with the excitation light source, the interrogation light source, the at least one light beam steering device, the light detector, and a memory storing instructions.
Claims
1. A system for non-invasively measuring at least one analyte within a blood vessel, the system comprising: an excitation light source having at least one excitation laser configured to selectively produce an excitation light beam at a predetermined excitation wavelength, wherein absorption by the analyte of an amount of the excitation light beam causes the analyte to produce a photoacoustic response; an interrogation light source having at least one interrogation laser configured to selectively produce an interrogation light beam at a predetermined interrogation wavelength; a Fabry-Perot sensor configured to be transparent to said excitation light beam, and to reflect at least some of the interrogation light beam; at least one light beam steering device; a light detector operable to receive light reflected from the Fabry-Perot sensor and produce signals representative of the received light; and a controller in communication with the excitation light source, the interrogation light source, the at least one light beam steering device, the light detector, and a memory storing instructions, the instructions when executed cause the controller to: control the light beam steering device to steer both the excitation light beam and the interrogation light beam relative to the Fabry-Perot sensor; and measure an amount of the analyte within the blood vessel using the signals representative of the received light.
2. The system of claim 1, wherein the system is configured to steer the excitation light beam and the interrogation light beam in unison in a direction of travel along a path relative to the Fabry-Perot sensor.
3. The system of claim 2, wherein the path is a Lissajous pattern.
4. The system of claim 2, wherein the at least one light beam steering device includes a two-axis micro-electro-mechanical (MEMS) mirror, and the instructions when executed cause the controller to control the two-axis MEMS mirror to steer the excitation light beam and the interrogation light beam in unison.
5. The system of claim 4, wherein the instructions when executed cause the controller to control the two-axis MEMS mirror using a resonant excitation.
6. The system of claim 5, wherein the system further comprises a sensor head configured for attachment to a subject, and the two-axis MEMS mirror and the Fabry-Perot sensor are disposed within the sensor head.
7. The system of claim 2, wherein the system is configured to produce the excitation light beam and the interrogation light beam substantially coincident with one another in a sensing area of the Fabry-Perot sensor.
8. The system of claim 2, wherein the system is configured to produce the excitation light beam at a first position on the path, and produce the interrogation light beam at a second position on the path, the second position lagging behind the first position on the path in the direction of travel.
9. The system of claim 2, wherein the at least one light beam steering device includes a first two-axis micro-electro-mechanical (MEMS) mirror and a second two-axis MEMS mirror, and the instructions when executed cause the controller to control the first MEMS mirror to steer the excitation light beam and to control the second MEMS mirror to steer the interrogation light beam in unison.
10. The system of claim 2, wherein the Fabry-Perot sensor has a sensing area, and the system is configured to produce the excitation light source to be incident to the Fabry-Perot sensor in an excitation incident area, and the excitation incident area is less than the sensing area.
11. The system of claim 1, wherein the excitation light source includes a plurality of said excitation lasers, wherein the excitation wavelength produced by each excitation laser is different from the respective excitation wavelength produced by every other of said excitation lasers.
12. The system of claim 11, wherein the instructions when executed cause the controller to operate the excitation lasers sequentially.
13. The system of claim 12, further comprising one or more optical fibers in communication with the excitation light source, the optical fibers configured to accept a plurality of the excitation wavelengths.
14. The system of claim 13, wherein the system is configured so that the light reflected from the Fabry-Perot sensor is received by the one or more optical fibers and passed to a light detector, the light detector configured to produce the signals representative of the received light and communication the signals to controller.
15. The system of claim 1, wherein the at least one interrogation light source includes a plurality of said interrogation lasers, wherein the interrogation wavelength produced by each interrogation laser is different from the respective interrogation wavelength produced by every other of said interrogation lasers.
16. The system of claim 15, wherein the instructions when executed cause the controller to operate the plurality of interrogation lasers sequentially.
17. The system of claim 16, further comprising one or more optical fibers in communication with the interrogation light source, the optical fibers configured to accept a plurality of the interrogation wavelengths.
18. The system of claim 1, wherein the Fabry-Perot sensor includes a plurality of alignment cells, each configured to provide position location information.
19. The system of claim 18, wherein each alignment cell is distinguishable from other said alignment cells by the position location information it is configured to provide.
20. The system of claim 19, wherein the Fabry-Perot sensor has a sensing area, and the plurality of alignment cells are disposed substantially outside the sensing area.
21. The system of claim 1, wherein the instructions when executed cause the controller to calibrate the Fabry-Perot sensor using a sensitivity map.
22. The system of claim 21, wherein the sensitivity map is based on scans of the Fabry-Perot sensor using an interrogation light beam at one or more interrogation wavelengths.
23. The system of claim 1, wherein the instructions when executed cause the controller to create a vascular map of tissue being sensed with the excitation light beam, the vascular map including a location of blood vessels within the tissue.
24. The system of claim 23, wherein the vascular map includes a respective location of one or more veins in the tissue and one or more arteries within the tissue based on relative amounts different analytes sensed within the blood vessels.
25. A method of non-invasively measuring at least one analyte within a blood vessel, the method comprising: providing a system having an excitation light source with at least one excitation laser configured to selectively produce an excitation light beam at a predetermined excitation wavelength, an interrogation light source having at least interrogation laser configured to selectively produce an interrogation light beam at a predetermined interrogation wavelength, a Fabry-Perot sensor configured to be transparent to said excitation wavelength light, and to reflect at least a portion of the interrogation light beam, at least one light beam steering device, a light detector, and a controller; using the at least one light beam steering device to steer the excitation light beam and the interrogation light beam in unison in a direction of travel along a path relative to the Fabry-Perot sensor, wherein absorption by the analyte of an amount of the excitation light beam causes the analyte to produce a photoacoustic response; receiving light reflected from the Fabry-Perot sensor, and using the light detector to produce signals representative of the received light and communicate the signals to the controller; and measuring an amount of the analyte within the blood vessel using the signals representative of the received light.
26. The method of claim 25, further comprising calibrating the Fabry-Perot sensor using a sensitivity map.
27. The method of claim 26, further comprising scanning the Fabry-Perot sensor using an interrogation light beam at one or more interrogation wavelengths, and producing the sensitivity with light reflected from the Fabry-Perot sensor during the scanning.
28. The method of claim 25, further comprising creating a vascular map of tissue being sensed with the excitation light beam, the vascular map including the location of blood vessels within the tissue.
29. The method of claim 28, wherein the vascular map includes the location of one or more veins in the tissue and one or more arteries within the tissue based on relative amounts different analytes sensed within the blood vessels.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
DETAILED DESCRIPTION
[0038] The present disclosure is directed to a system and method for continuously and non-invasively measuring analytes within blood vessels. As used herein, the term “blood vessel” is intended to include veins, arteries, or capillaries of a subject, or any combination thereof. The present disclosure is operable to measure a plurality of different analytes, including oxyhemoglobin (“HbO2”) and deoxyhemoglobin (“Hb”) in blood vessels. Hemoglobin (in both oxygenated and deoxygenated states) has a substantially high concentration within a blood sample, and has a substantially high absorption coefficient. The present disclosure is, therefore, well suited to sensing and measuring hemoglobin. The present disclosure is not, however, limited to sensing and measuring Hb and HbO2. Additional non-limiting examples of analytes that may be measured include endogenous analytes such as methemoglobin, carboxyhemoglobin, water, melanin, lipids content, and carbon monoxide, and exogenous analytes such as indocyanine green, methylene blue dye, and the like. Signal data collected using the present disclosure can be used to determine physiological/hemodynamic parameters, such as oxygen saturation, cardiac output, etc.
[0039] Referring to
[0040] The sensor head 28 is configured for attachment to a subject in a position where excitation light can access blood vessels containing analytes of interest. The sensor head 28 shown in
[0041] The excitation light source 22 is operable to produce light at a plurality of predetermined wavelengths: e.g., in a pulsed mode. In some embodiments, the excitation light source 22 includes a plurality of lasers (referred to hereinafter as “excitation lasers 40”), each configured to emit a light beam at a particular wavelength of light. Each excitation laser 40 may be configured to emit a light beam at a wavelength of light different from that emitted from the other excitation lasers 40. The wavelength of each excitation laser 40 is chosen based on its ability to produce a photoacoustic effect (sometimes referred to as an “optoacoustic effect”) when light emitted by the excitation laser 40 is sufficiently absorbed by a target analyte. The term “photoacoustic effect” as used herein refers to the phenomenon that occurs when light at a particular wavelength is presented to and absorbed by the target analyte, thereby causing an increase in kinetic energy of the target analyte and consequent pressure response from the analyte in the form of an acoustic wave.
[0042] In some embodiments, the excitation light source 22 is configured to produce an excitation light beam 72 that includes light produced by at least one of the excitation lasers 40. Optical beam combiners 42 (e.g., a dichroic mirror) may be used to add light from each respective excitation laser 40 into the excitation light beam 72 prior to the excitation light beam 72 being presented to the sensor head 28 for application to the subject.
[0043] In some embodiments, the ultrasound receiving mechanism includes a Fabry-Perot sensor 38 and an interrogation light source 34 having at least one interrogation laser 54.
[0044] In some embodiments, the interrogation light source 34 includes a plurality of interrogation lasers 54. As will be explained herein, using a plurality of interrogation lasers 54, each emitting at light beam at a different wavelength, may provide an improved ability to detect deformations of the Fabry-Perot sensor 38, and therefore acoustic waves. The interrogation light source 34 is configured to produce an interrogation light beam 70 that includes light produced by at least one of the interrogation lasers 54. Optical beam combiners 42 may be used to add light from each respective interrogation laser 54 into the interrogation light beam 70.
[0045] Referring to
[0046] The light beam steering device 36 is operable to: a) receive input light beams from the excitation light source 22 (e.g., the excitation light beam 70) and the interrogation light source 34 (e.g., the interrogation light beam 72 or the plurality of parallel interrogation light beams), and to direct those light beams toward the Fabry-Perot sensor 38 and subject tissue; and b) to steer the aforesaid input light beams 70, 72 in unison in a predetermined pattern relative to the Fabry-Perot sensor 38 to permit light beam incidence of a select portion, or all, of the Fabry-Perot sensor 38. As explained below, the light beam steering device 36 of the present disclosure enables analyte sensing with an excitation light beam 72 presented to the tissue in a manner that facilitates meeting the requisite safety regulations, while at the same time provided an improved means for determining analyte information. The light beam steering device 36 is in communication with the controller 26 and the controller 26 may be configured to control the light beam steering device 36 as will be described below.
[0047] An example of an acceptable light beam steering device 36 is a two-axis micro-electro-mechanical mirror (referred to hereinafter as a “MEMS mirror 66”). Briefly stated, a two axis MEMS mirror 66 includes a mirror that can be controllably pivoted along two orthogonal axes. The reflection of a light beam from the mirror can therefore be controlled by selectively pivoting the mirror.
[0048]
[0049]
[0050] In some embodiments, the excitation and interrogation light beams 72, 70 are input into the light beam steering device 36 so that the aforesaid light beams are reflected from the light beam steering device 36 in a substantially coincident manner; e.g., see
[0051] In some embodiments, the light beam steering device 36 is configured so that the interrogation beam 70 and the excitation light beam 72 are not substantially coincident, but are steered together. For example, the interrogation beam 70 may be oriented to positionally lag behind the excitation beam 72. Referring to
[0052] As stated above, the light beam steering device 36 can be used to steer the excitation and interrogation light beams 72, 70 in a predetermined pattern relative to the Fabry-Perot sensor 38 to permit light beam incidence of a select portion, or all, of the Fabry-Perot sensor 38. In some embodiments the two axis MEMS mirror 66 can be controlled to steer the excitation and interrogating laser beams 72, 70 in a Lissajous pattern; e.g., see
[0053] As will be explained below, in some embodiments the light beam steering device 36 may be used to steer the interrogation light beams to obtain a sensitivity map for the Fabry-Perot sensor 38 (e.g., see
[0054] The Fabry-Perot sensor 38 is configured with internal surfaces that reflect light at select wavelengths, and configured to be transparent to light at other wavelengths. In the present disclosure, the Fabry-Perot sensor 38 is configured to be transparent to the excitation light beam 72 wavelengths and reflects the interrogation light beam 70 wavelengths. Hence, the excitation light beam 72 passes through the Fabry-Perot sensor 38 and is incident to the aligned tissue region.
[0055] In some embodiments, the Fabry-Perot sensor 38 may include reflectance-encoded alignment cells 76 (e.g., see
[0056] The controller 26 is in communication with excitation light source 22, the ultrasound receiving mechanism, the light beam steering device 36, and other components within the present disclosure system 20 to perform the functions described herein. The controller 26 may include any type of computing device, computational circuit, processor(s), CPU, computer, or the like capable of executing a series of instructions that are stored in memory. The instructions may include an operating system, and/or executable software modules such as program files, system data, buffers, drivers, utilities, and the like. The executable instructions may apply to any functionality described herein to enable the system 20 to accomplish the same algorithmically and/or coordination of system components. The controller 26 may include a single memory device or a plurality of memory devices. The present disclosure is not limited to any particular type of non-transitory memory device, and may include read-only memory, random access memory, volatile memory, non-volatile memory, static memory, dynamic memory, flash memory, cache memory, and/or any device that stores digital information. The controller 26 may include, or may be in communication with, an input device 78 that enables a user to enter data and/or instructions, and may include, or be in communication with, an output device 80 configured, for example to display information (e.g., a visual display or a printer), or to transfer data, etc. Communications between the controller 26 and other system 20 components may be via a hardwire connection or via a wireless connection. As stated above, the controller 26 may in communication with the excitation laser control unit 52 and/or with the interrogation laser control unit 68, or the aforesaid control units may be integrated with the controller 26.
[0057] In the operation of the present disclosure system 20 and method, the sensor head 28 is mounted on the subject in a region where excitation light can access blood vessels to be sensed; e.g., a digit of the subject. As indicated above, a couplant 32 may be disposed between the sensor head 28 and the subject's skin tissue to improve optical signal transmission into the subject's tissue and/or acoustic signal transmission out of the subject's tissue.
[0058] In some instances, the present disclosure may include a procedure for aligning and/or controlling scan modes of the light beams 70, 72 relative to the Fabry-Perot sensor 38. Such a procedure may not be necessary in all instances and is therefore an optional aspect of the present disclosure. A non-limiting example of an alignment procedure utilizes a Fabry-Perot sensor 38 having reflectance-encoded alignment cells 76 attached to the Fabry-Perot sensor 38. At least one interrogating light beam is provided to the sensor head 28 and is incident to the light beam steering device 36 (e.g., the two axis MEMS mirror 66). The light beam steering device 36 is controlled to direct the interrogating light beam 70 in a predetermined scan pattern over the Fabry-Perot sensor 38 to ascertain the positions of the reflectance-encoded alignment cells 76; e.g., ascertain orthogonal coordinates (e.g., Xi, Yi, etc.) for each alignment cell 76. Once the alignment cell positions are determined, a steering pattern (e.g., a Lissajous pattern) can be selected based on the alignment cell positions. In some embodiments, the location of the alignment cells 64 may be inferred from a known preset steering pattern (e.g., a steering pattern such as that used during resonant operation), such that corrections for the Fabry-Perot sensor 38 sensitivity can take place periodically or as required by the application at hand.
[0059]
[0060] In some embodiments, the present disclosure may include a procedure for calibrating the performance of the ultrasound receiving mechanism. A non-limiting example of such a calibrating procedure includes the determination of a sensitivity map 74 that provides information regarding the uniformity of the photometric response/sensitivity of the sensor 38 to interrogating light beams 70 at a plurality of different wavelengths. The sensitivity map 74 shown in
[0061] Once any initial procedures that may be required are performed, the present disclosure system 20 can be operated to sense and measure target analytes that may be present within the subject's blood vessel. For example, the controller 26 may execute stored instructions that cause the excitation light source 22 to produce an excitation light beam 72 that includes a particular wavelength of light, and cause the interrogation light source 34 to produce an interrogation light beam 70 that includes one or more wavelengths of light. In some embodiments, the controller 26 may control the excitation light source 22 to vary the wavelength(s) of the excitation light beam 72; e.g., by sequentially operating the respective excitation lasers 40 (e.g., EL1, EL2 . . . ELN) and adding the respective individual light beams into the excitation light beam 72. In some embodiments, the excitation light beam 72 may include light at more than one wavelength. In similar fashion, the controller 26 may control the interrogation light source 34 to vary the wavelength(s) of the interrogation light beam 70; e.g., by sequentially operating the respective interrogation lasers 54 (e.g., IL1, IL2 . . . ILN) and adding the respective individual light beams into the interrogation light beam 72. In some embodiments, the interrogation light beam 70 may include light at more than one wavelength. The controller 26 may execute stored instructions that cause the light beam steering device 36 (e.g., the two axis MEMS mirror 66) to direct the light beams along a selected steering pattern (e.g., a Lissajous pattern) relative to the Fabry-Perot sensor 38. As indicated above, in some embodiments, the excitation and interrogation light beams 72, 70 may be substantially coincident as the light beams traverse the selected steering pattern; e.g., the footprint of the excitation light beam 72, as projected onto the tissue, encompasses the area of the Fabry-Perot sensor 38 that is being read with the interrogating light beam 70. In other embodiments, the interrogation light beam 70 may positionally lag behind the excitation light beam 72 as the light beams traverse the selected steering pattern. In both these embodiments, the interrogation light beam 70 and the excitation light beam 72 are steered together along the selected steering pattern. Once the selected steering pattern is completed, the process may be repeated with the excitation light source 22 producing a light beam at a different wavelength. The process may be repeated as many times as required to capture the desired signal data; e.g., “N” cycles for “N” different excitation wavelengths.
[0062] During tissue sensing, the excitation light beams 72 pass through the Fabry-Perot sensor 38 (which is transparent to the excitation light wavelengths) and enter the aligned tissue region. As indicated above, each excitation light wavelength is chosen as one that will produce a photoacoustic effect when light at that wavelength is presented to and absorbed by the target analyte, thereby causing the analyte to produce a response in the form of acoustic waves. At least some of the aforesaid acoustic waves traverse to the skin of the tissue being sensed where they engage with the Fabry-Perot sensor 38. The acoustic waves engaging with the Fabry-Perot sensor 38 cause the sensor 38 to change from its default configuration to a deformed configuration. The interrogating light beam incident to the Fabry-Perot sensor 38 reflects from the sensor 38. The characteristics of the reflected light are a function of the acoustic waves deforming the Fabry-Perot sensor 38 and therefore a function of the photoacoustic effect caused by the target analyte absorbing the excitation light. At least some of the reflected light is collected within the sensor head 28; e.g., received by the objective optics 50, directed to the light beam steering device 36, which in turn directs the collected light to the optical fiber 56 acting as a light conduit between sensor head 28 and the interrogation light source 34. Upon reaching the beam splitter 58 (e.g., see
[0063] In some embodiments, the controller 26 may include stored instructions that when executed cause the controller 26 to create a vasculature map of the tissue region being sensed. For example, the stored instructions may include an algorithm that uses the signals from the detector 60 to identify a predominant section of blood vessels within the sensed tissue. The type of blood vessel (i.e., an artery or a vein) may be determined using, for example, spectroscopic means. For example, the stored instructions may use the detector signals to determine relative levels of a first analyte (oxyhemoglobin—HbO2) and a second analyte (deoxyhemoglobin—HB) within the blood flow in a given vessel. In some instances, the nature of the vessel (e.g., vein or artery) may be inferred from the relative levels of Hb and HbO2. To give a specific non-limiting example, if the concentration of oxyhemoglobin within the blood flow is above a predetermined level, the blood vessel may be identified as an artery. Conversely, if the concentration of deoxyhemoglobin within the blood flow is above a predetermined level, the blood vessel may be identified as a vein. The present disclosure is not limited to any particular algorithmic steps for identifying vessels and producing a vasculature map therefrom. In some embodiments, the subject tissue may be continuously sensed, and the vasculature map shown in real time. As can be seen from
[0064] While various inventive aspects, concepts and features of the disclosures may be described and illustrated herein as embodied in combination in the exemplary embodiments, these various aspects, concepts, and features may be used in many alternative embodiments, either individually or in various combinations and sub-combinations thereof. Unless expressly excluded herein all such combinations and sub-combinations are intended to be within the scope of the present application. Still further, while various alternative embodiments as to the various aspects, concepts, and features of the disclosures—such as alternative materials, structures, configurations, methods, devices, and components, alternatives as to form, fit, and function, and so on—may be described herein, such descriptions are not intended to be a complete or exhaustive list of available alternative embodiments, whether presently known or later developed. Those skilled in the art may readily adopt one or more of the inventive aspects, concepts, or features into additional embodiments and uses within the scope of the present application even if such embodiments are not expressly disclosed herein. For example, in the exemplary embodiments described above within the Detailed Description portion of the present specification, elements are described as individual units and shown as independent of one another to facilitate the description. In alternative embodiments, such elements may be configured as combined elements. As a specific example, in the description above, the controller 26, the excitation light source 22, the interrogation light source 34, and the sensor head 28 are each described as an element and are shown in the Figures as being independent of one another to facilitate the description. The present disclosure contemplates that one or more of these elements may be combined with another element and still be in keeping with the teachings of the present disclosure. For example, in some embodiments the excitation light source 22, the interrogation light source 34, and the controller 26 may be integrated into the sensor head 28.
[0065] Additionally, even though some features, concepts, or aspects of the disclosures may be described herein as being a preferred arrangement or method, such description is not intended to suggest that such feature is required or necessary unless expressly so stated. Still further, exemplary or representative values and ranges may be included to assist in understanding the present application, however, such values and ranges are not to be construed in a limiting sense and are intended to be critical values or ranges only if so expressly stated.
[0066] Moreover, while various aspects, features and concepts may be expressly identified herein as being inventive or forming part of a disclosure, such identification is not intended to be exclusive, but rather there may be inventive aspects, concepts, and features that are fully described herein without being expressly identified as such or as part of a specific disclosure, the disclosures instead being set forth in the appended claims. Descriptions of exemplary methods or processes are not limited to inclusion of all steps as being required in all cases, nor is the order that the steps are presented to be construed as required or necessary unless expressly so stated. The words used in the claims have their full ordinary meanings and are not limited in any way by the description of the embodiments in the specification.